Objective: To examine histopathologic and immunohistochemical features of human corneal buttons from patients who developed keratoglobus.
Patients with this condition have severe visual impairment due to extreme myopia, irregular astigmatism, corneal scarring, and the occasional corneal rupture. 3 Keratoglobus has been described as both an acquired and a congenital disease. Acquired keratoglobus has been associated with dysthyroid ophthalmopathy, vernal keratoconjunctivitis, and chronic marginal blepharitis. [4] [5] [6] Eye rubbing has been proposed to be the major contributing factor in the latter 2 entities. 2 The congenital form of the disease has been associated with Leber congenital amaurosis 7 and the blue sclera syndrome. [8] [9] [10] Keratoglobus is also associated with other connective tissue disorders, including Ehlers-Danlos syndrome type VI, 11 Marfan syndrome, 12 and RubinsteinTaybi syndrome. 13 Studies of the histologic changes in keratoglobus have been rare. Reported findings include marked stromal thinning with scarring, frequent disruptions, or complete absence of Bowman's layer; breaks in Descemet's membrane; and thickening of Descemet's membrane. 2, 14 Keratoglobus and keratoconus are both noninflammatory ectatic disorders of the cornea. The distinction between the 2 similar conditions was first made by Cavara in 1950 . 1 The cornea in keratoglobus is diffusely thinned, often more markedly in the peripheral cornea, whereas in keratoconus the thinning is most prominent in the central cornea. The histopathologic changes seen in keratoglobus, including disruption of Bowman's layer and Descemet's membrane breaks, are very similar to those seen in advanced keratoconus. 15 In fact, the histologic similarities have led to the speculation that keratoglobus may be an end-stage manifestation of advanced keratoconus. 14 The biochemical abnormalities found in keratoconus have not been studied in keratoglobus. These biochemical alterations include decreased expression of the protease inhibitor ␣1-proteinase inhibitor (␣1-PI, formerly also known as ␣1-antitrypsin) and upregulation of transcription factor Sp1. [16] [17] [18] In addition, matrix metalloproteinases (MMPs), a group of enzymes that are involved in tissue remodeling, have also been examined. Among them, MMP-1 and membrane type (MT)-MMP-1 have been reported to be upregulated in corneas with keratoconus. [19] [20] [21] [22] In this study, we examined the histopathologic characteristics of keratoglobus using light microscopy and performed immunohistochemistry to determine if biochemical alterations in keratoglobus shared features with those documented in keratoconus.
METHODS
Nine corneal buttons were obtained at the time of penetrating keratoplasty from 9 patients who had clinically diagnosed keratoglobus at the University of Illinois at Chicago or the L.V. Prasad Eye Institute, Hyderabad, India. Two normal human corneal buttons from donors (ages 25 and 69 years) were obtained from the Illinois Eye Bank, Chicago, within 24 hours of death. None of the donors had known ocular diseases, and their corneas were clear and unremarkable. Two corneal buttons from patients with typical features of keratoconus (ages 40 and 48 years) were obtained following transplantation from the cornea service at the University of Illinois at Chicago as another set of controls. The corneas that were excised from normal human eyes and keratoglobus and keratoconus buttons were fixed in 10% buffered formalin, processed, and embedded in paraffin.
The thickness of the stroma in the central and midperipheral cornea was measured in hematoxylin-eosinstained sections using AxioVision software, version 4.4.1.0 (Carl Zeiss MicroImaging Inc, Gottingen, Germany) after being photographed under a Zeiss Axioskop 2 Plus microscope using a Zeiss AxioCam camera (Carl Zeiss MicroImaging Inc). Statistical analysis was performed using the Wilcoxon signed-rank test to compare stromal thickness in the central and mid-peripheral cornea. P Ͻ .05 was considered statistically significant.
Immunohistochemical studies were also conducted. The sections were incubated at 4°C with primary antibodies for 16 hours. The primary antibodies used in the study included (1) a polyclonal goat antibody to ␣1-PI (1:200; MP Biomedicals, Aurora, Ohio), (2) a polyclonal rabbit antibody to Sp1 (PEP 2, 1:100; Santa Cruz Biotechnology, Santa Cruz, California), (3) a polyclonal rabbit anti-MMP-1 antibody (1:100; Laboratory Vision, Fremont, California), (4) a monoclonal mouse antibody specific to MMP-2 (A-Gel VC2, 1:50; Laboratory Vision), and (5) a monoclonal mouse antibody to MMP-3 (SL-1 IID4, 1:20; Laboratory Vision). Before primary antibody incubation for MMPs, an antigen retrieval method was applied on each section with 8M buffered urea (pH 3.5) at room temperature for 2 hours. Biotinylated donkey anti-goat IgG (1:250), donkey anti-rabbit IgG (1:250), and donkey anti-mouse IgG (1:250; all from Jackson ImmunoResearch, West Grove, Pennsylvania) were used as secondary antibodies at room temperature for 45 minutes. The color reaction for the anti-Sp1 was carried out with Fast Red TR/Naphthol AS-MX phosphate (Sigma, St Louis, Missouri) after sections were incubated with alkaline phosphatase-conjugated ExtrAvidin (1:50; Sigma). For ␣1-PI, MMP-1, MMP-2, and MMP-3, sections were incubated with avidin-biotin complex (Vectastain; Vector Laboratories, Burlingame, California) for 45 minutes followed by incubation with 3,3 diaminobenzidine tetrahydrochloride (Sigma). After mounting in Permount (Thermo Fisher Scientific, Waltham, Massachusetts, for ␣1-PI, MMP-1, MMP-2, and MMP-3) or aqueous mounting fluid (Vectashield; Vector Laboratories, for Sp1), the staining intensity in each experiment was scored by 3 masked observers on a scale from 0 to 3, with 0 indicating no staining and 3 the most intense staining. Each experiment was repeated twice. Statistical analysis was performed using the MannWhitney U test to compare the staining intensity of keratoglobus and keratoconus corneas with those from normal controls. Within the corneas with a keratoglobus, immunostaining intensity was compared between the central and mid-peripheral areas. P Ͻ .05 was considered statistically significant.
RESULTS

CLINICAL HISTORY
Nine patients with the diagnosis of keratoglobus (6 female, 3 male) had penetrating keratoplasty at a mean age of 27 years (range, 3-49 years). Clinical histories were available for 7 of the 9 patients, all of whom presented with varying complaints of bilateral visual loss and had bilateral keratoglobus clinically diagnosed. Preoperative best-corrected visual acuity ranged from 20/60 to light perception. Penetrating keratoplasty was performed on 1 eye in all 9 patients. The salient ophthalmic findings are summarized in Table 1 and 
HISTOLOGIC ANALYSIS
Measurements of corneal stromal thickness were performed on histologic specimens of all 9 keratoglobus corneas. Five measurements taken in each of the following areas of the cornea were then averaged: center, right midperiphery, and left mid-periphery (mid-peripheral cornea refers to the peripheral portions of the excised corneal button; this region would vary depending on the size of the corneal button and size of the cornea). The mean mid-peripheral stromal thickness (212 µm [standard deviation (SD), 89 µm]) was significantly thinner than that in the central cornea (244 µm [98 µm], P=.05). For comparison, normal control stromal thickness was 399 µm (SD, 5.7 µm) centrally and 430 µm (SD, 7.1 µm) peripherally. Details of thickness measurements are reported in Table 2 .
The corneas with a keratoglobus had a range of findings on histology ( Table 3) . These included focal Bowman's layer disruption and diffuse stromal thinning that was especially evident in the peripheral cornea in all keratoglobus buttons. Epithelial hyperplasia in the central cornea was observed in 3 buttons, stromal scarring in 5, stromal neovascularization in 4, focal disruptions of Descemet's membrane in 5, and diffuse Descemet's membrane thickening in 2. Inflammatory infiltrates were not seen in any of the keratoglobus buttons. The cases in Figure 2 and Figure 3 are illustrative of the spectrum of histologic changes observed in our series of keratoglobus cases.
IMMUNOHISTOCHEMICAL ANALYSIS
Immunohistochemical experiments demonstrated decreased immunostaining for ␣1-PI in the epithelia of corneas with keratoglobus or keratoconus that was statistically significant when compared with normal controls (P =.01) (Figure 4) . Immunolabeling for Sp1 in the nuclei of epithelial cells in both keratoglobus and keratoconus corneas was significantly increased compared with normal controls (P = .01) (Figure 4) . The keratoglobus and keratoconus showed similar immunostaining intensity. However, unlike in keratoconus corneas, the abnormal staining patterns for both ␣1-PI and Sp1 in keratoglobus were more prominently observed in the mid-peripheral than in the central cornea. Each of these differences were statistically significant (␣1-PI, P = .04; Sp1, P = .049). The corneas with keratoglobus had significantly higher epithelial stain- ing intensities for MMP-1, MMP-2, and MMP-3 than corneas from normal control, in which staining was nearly absent (P = .01). The staining intensity of MMP-1 in the epithelia of corneas with keratoconus was also higher than in normal controls, whereas MMP-2 and MMP-3 immunolabeling in the keratoconus cases was absent or at the background level. Although positive epithelial staining for each MMP in keratoglobus was globally observed, it was more notable in the basal epithelium and in areas where the underlying Bowman's layer was disrupted ( Figure 5 ).
Semiquantitative immunostaining results for all antibodies are displayed in Figure 6 (␣1-PI and Sp1) and Figure 7 (MMP-1, MMP-2, and MMP-3). Measurement of immunohistochemical staining intensity within keratocytes was difficult given the appearance of the nuclear counterstain (hematoxylin). No positive staining above background levels was detected within the stromal extracellular matrix, including in areas where stromal scarring was observed.
COMMENT
This study examined the histologic and immunohistochemical features of corneas obtained from 9 patients with a keratoglobus. The histologic findings in these keratoglobus buttons were consistent with those reported in the literature, 2,14 including marked stromal thinning with scarring, frequent disruptions, and complete absence of Bowman's layer; breaks in Descemet's membrane; and thickening of Descemet's membrane. Additionally, stromal neovascularization was noted in 4 of our specimens. Stromal vascularization was associated with clinically documented corneal perforation (case 2) or breaks in Descemet's membrane with stromal edema.
Immunohistochemistry performed on corneas with keratoglobus and keratoconus and in normal controls revealed that the expression of ␣1-PI and Sp1 in keratoglobus was similar to that of keratoconus. Previous reports have described a decrease in ␣1-PI expression and upregulation of transcription factor Sp1 in corneas with keratoconus. 17, 18 Additionally it was found that Sp1 overexpression suppresses the promoter activity of the ␣1-PI gene, which conceivably alters tissue degradation processes in corneas with keratoconus. 16 We observed similar biochemical changes in our keratoglobus specimens. Such a finding suggests that the mechanisms by which corneal stromal thinning develops in keratoglobus may bear similarities to those in keratoconus. Interestingly, the abnormal staining patterns in keratoglobus were more prominently observed in the mid-peripheral cornea than in the central cornea for both ␣1-PI and Sp1. This is consistent with clinical and histological observations for keratoglobus that corneal thinning is more pronounced in the peripheral cornea both in our group of patients and elsewhere. An increase in the expression of MMP-1 and MT-MMP-1 has been described in areas of central thinning in corneas with keratoconus. [19] [20] [21] [22] Matrix metalloproteinases have also been implicated in various other corneal conditions, including wound repair and healing, ulcerations, and diabetic corneas. 23 Our results showed that the MMP-1, MMP-2, and MMP-3 immunostaining intensity in keratoglobus was significantly higher than that seen in normal controls. The MMP-1 immunolabeling was also somewhat elevated in keratoconus corneas, whereas the MMP-2 and MMP-3 staining was comparable with normal controls. The MMP immunostaining was observed diffusely throughout the entire keratoglobus cornea, though it was more notable in the basal epithelium in areas where the underlying Bowman's layer was disrupted. In comparison, the MMP-1 immunoreactivity in keratoconus was localized to the central portion of the cornea. It appears thus that the MMP-1-mediated protein degradation may be occurring at the active sites of both conditions, diffusely in keratoglobus and centrally in keratoconus. In addition, the finding that MMP-2 and MMP-3 were increased in corneas with keratoglobus compared with those with keratoconus may explain the diffuse and augmented stromal thinning seen in the former. It is possible that the increased MMP may have a role in disrupting Bowman's layer in keratoglobus, as suggested by the intense immunolabeling of MMP-1, -2, and -3 in these specific areas. In keratoconus, it has also been shown previously that the patients' corneas contain a decreased level of tissue inhibitor of MMP-1 that may contribute to alterations in the MMP-2 activity. 24 The role of tissue inhibitor of MMP-1 in keratoglobus needs to be further explored.
In summary, the current results suggest that the stromal thinning in keratoglobus and keratoconus may arise via degradation processes and that the 2 conditions may share common, as-yet-unclear patho- Immunostaining results for ␣1-proteinase inhibitor (␣1-PI) and Sp1. There is intense staining of ␣1-PI in the epithelium of the normal control. By comparison, epithelial staining in both corneas with keratoglobus and the cornea with keratoconus is markedly reduced (chromogen 3,3-diaminobenzidine tetrahydrochloride). The intensity of Sp1 nuclear staining is much lower in the epithelium of the normal control compared with that in keratoglobus and keratoconus (chromogen Fast Red TR/Naphthol AS-MX phosphate staining). The abnormal staining patterns in the keratoglobus corneas were more prominently observed in the mid-peripheral than the central cornea for both ␣1-PI and Sp1. Scale bars equal 50 µm for all. genic pathways, though extra degradative events may be occurring additionally in keratoglobus. A similar theory was suggested previously by Pouliquen et al 14 based on histological findings alone. 
